AmpliSens® HPV HCR-screen-FEP

Cat. Number: V31-3x-FEP-CE

Fluorescence End Point PCR kit for qualitative detection of HPV HCR types types 16, 18, 31, 33, 35, 39, 45, 52, 58, 59, 67

AmpliSens® HPV HCR screen-FEP PCR kit is an in vitro nucleic acid amplification test for qualitative detection of high carcinogenic risk (HCR) human papillomaviruses (HPV) types 16, 18, 31, 33, 35, 39, 45, 52, 58, 59, 67 DNA in the clinical material (cervical and urethral scrapes) by using end-point hybridization-fluorescence detection.

Recommended extraction kits: DNA-sorb-AM (K1-12-100-CE), DNA-sorb-C (K1-6-50-CE), DNA-sorb-В (K1-2-100-CE). It is possible to use other nucleic acid extraction protocols.

Adapted for:

  • Gradient Palm Cycler (Corbett Research, Australia)
  • Maxygene (Axygen, USA) 

Информация для заказа
Наименование
Кат. №
Комплектация
AmpliSens® HPV HCR-screen-FEP
V31-3x-FEP-CE
FEP Kit with reagents only for amplification step All reagents are in individual vials (no PCR-tubes) + Taq-F polymerase (“hot start”)
*Check the presence of a registration certificate.
In its absence, the product is not intended for medical purposes in the territory of the Russian Federation.
**RUO- the product is not intended for medical purposes in the territory of the Russian Federation

PCR is the basic method when working with nucleic acids, allows you to multiply the number of copies of the target DNA site and determine the initial concentration of the desired sequences during real-time analysis time.

In addition, this method has been widely used in molecular diagnostics for the determination of pathogens infectious diseases and predispositions to hereditary diseases. Cooling and heating of samples with the necessary frequency and duration required for conducting PCR, provided by special devices – amplifiers (thermal cyclers).

Copyright© ООО «ILS» 2002-2024г. All rights reserved Information on the site is not a public offer.
x
Our website uses cookies and similar technologies for the convenience of users. By continuing to use the site, you agree to the use of cookies.